Ferrer

Ferrer logo.jpg

Contact information

Ferrer
Dr. Andrés G. Fernández, Ferrer Advanced Biotherapeutics, Director
Avda. Diagonal 549
5ª planta
Barcelona
936003700
934914720
Areas of activity
  • A. Health Biotechnology
  • A. Health Biotechnology
  • Therapeutic areas
  • A. Health Biotechnology
  • Therapeutic areas
  • Analgesia & Pain
  • A. Health Biotechnology
  • Therapeutic areas
  • Dermatology
  • A. Health Biotechnology
  • Therapeutic areas
  • Cardiovascular diseases and circulatory system
  • A. Health Biotechnology
  • Therapeutic areas
  • Genetic and rare diseases
  • A. Health Biotechnology
  • Therapeutic areas
  • Infectious diseases
  • A. Health Biotechnology
  • Therapeutic areas
  • Immunology
  • A. Health Biotechnology
  • Therapeutic areas
  • Ophtalmology and optometry
  • A. Health Biotechnology
  • Therapeutic areas
  • Oncology
  • A. Health Biotechnology
  • Therapeutic areas
  • Blood and lymphatic system
  • A. Health Biotechnology
  • Therapeutic areas
  • Digestive system and hepatology
  • A. Health Biotechnology
  • Therapeutic areas
  • Kidney and genitourinary system
  • A. Health Biotechnology
  • Therapeutic areas
  • Central nervous system
  • A. Health Biotechnology
  • Therapeutic areas
  • Respiratory and pulmonary system
  • A. Health Biotechnology
  • Areas of activity
  • A. Health Biotechnology
  • Areas of activity
  • Biomarkers
  • A. Health Biotechnology
  • Areas of activity
  • Stem cells
  • A. Health Biotechnology
  • Areas of activity
  • Medical devices
  • A. Health Biotechnology
  • Areas of activity
  • Drug development
  • A. Health Biotechnology
  • Areas of activity
  • Cellular Therapy
  • A. Health Biotechnology
  • Areas of activity
  • Gene Therapy
  • A. Health Biotechnology
  • Areas of activity
  • Biomaterials and tissue therapy
  • A. Health Biotechnology
  • Areas of activity
  • Vaccines
  • B. Agrifood Biotechnology
  • B. Agrifood Biotechnology
  • Food
  • B. Agrifood Biotechnology
  • Food
  • Functional Food

Ferrer is a private pharmaceutical group that works for the wellbeing of society through the promotion of health. It has a direct presence in 26 countries and its products are present in more than 90 territories. Ferrer is characterized by the diversification of its business covering drug prescription, vaccines, molecular diagnostics, OTC and food additives. The company maintains a high investment in R&D of new therapies and diagnostics. 

Products and services

Ferrer is currently active in the clinical development of new drugs in spinal cord injury, infectious diseases and sleep disorders. It also develops projects under the "polypill" concept, as the recently launched Trinomia, to facilitate treatment compliance and the rationalization of costs for the health systems.

Ferrer Advanced Biotherapeutics (FAB), the Biotech Research Division of Ferrer Internacional, identifies, promotes and develops therapeutic and diagnostic projects in collaboration with external groups. Projects, based on cutting-edge technology platforms, provide high added value solutions in fields such as CNS, cardiovascular, oncology, dermatology, ophthalmology and gastroenterology.

Epicup, a new cancer of unknown primary diagnostics system based on epigenetic markers, is the first product fully developed by FAB.